The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...
The first men have taken part in a major UK trial testing new ways to screen for prostate cancer and detect the disease earlier ...
Medlife Crisis on MSN
A 23-year study reveals the hidden reality behind cancer testing
A major 23-year study on prostate cancer screening reveals that while more cases are detected, the actual reduction in death ...
Sir Chris Hoy has issued a powerful plea for men to undergo prostate cancer screening, as he unveiled a significant project ...
Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 ...
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
Scans that makes prostate cancer cells "glow" could cut the need for invasive biopsies, according to new research.
Scans that makes prostate cancer cells "glow" could cut the need for invasive biopsies, according to new research. The state-of-the-art imaging test could safely halve the number of men who need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results